The test–retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Brain presynaptic dopaminergic function can be assessed using 18F-DOPA positron emission tomography (PET). Regional 18F-DOPA utilization may be used to index dopaminergic abnormalities over time or dopaminergic response to treatment in clinical populations. Such studies require prior knowledge of the stability of the 18F-DOPA signal in the brain regions of interest. Test-retest reliability was examined in eight healthy volunteers who each received two 18F-DOPA PET scans, approximately two years apart. 18F-DOPA utilization (kicer) was determined using graphical analysis relative to a reference tissue input (Patlak et al., 1983). Reproducibility (measured as the within-subjects variation) and reliability (measured as intraclass correlation coefficients, ICCs), of 18F-DOPA kicer was assessed in the structural and functional subdivisions of the striatum and select extrastriatal brain regions. Voxel-based median ICC maps were used to visualize the distribution of 18F-DOPA kicer reliability across the brain. The caudate and putamen, and associative and sensorimotor, striatal subdivisions showed good reliability across the two scan sessions with bilateral ICCs ranging from 0.681 to 0.944. Reliability was generally lower in extrastriatal regions, with bilateral ICCs ranging from 0.235 in the amygdala to 0.894 in the thalamus. These data confirm the utility of 18F-DOPA PET in assessing dopaminergic function in the striatum and select extrastriatal areas, but highlight the limitations in using this approach to measure dopaminergic function in low uptake extrastriatal brain areas. This information can be used to optimize the experimental design of future studies investigating changes in brain dopaminergic function with 18F-DOPA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Forming inferences about some intraclass correlation coefficients.
McGraw, K. O., & Wong, S. P. (1996) · Psychological Methods · doi:10.1037/1082-989x.1.1.30 · Cited by 6,903
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Self-citationAmphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706
Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525 · cited 3×
“…scanner resolution have enabled striatal regions to be subdivided along anatomical or functional lines (Drevets et al., 2001; Martinez et al., 2003; Mawlawi et al., 2001), and while the reliability of this has been evaluated for imaging D2 receptors (Martinez et al., 2003), it has not been…”
BackgroundInfluentialMeasuring fMRI reliability with the intra-class correlation coefficient
Caceres, A., Hall, D. L., Zelaya, F. O., Williams, S. C. R., & Mehta, M. A. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.035 · Cited by 255
Self-citation
Research works printed but not linked: 46
- Bose, 2008, Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging, Schizophr. Res., 106, 148, 10.1016/j.schres.2008.09.011 · DOI
- Bouchard, 1981, Characteristics of dihydroxyphenylalanine/5-hydroxytryptophan decarboxylase activity in brain and liver of cat, J. Neurochem., 37, 781, 10.1111/j.1471-4159.1982.tb12555.x · doi:10.1111/j.1471-4159.1982.tb12555.x
- Brooks, 2003, Imaging end points for monitoring neuroprotection in Parkinson's disease, Ann. Neurol., 53, S110, 10.1002/ana.10480 · DOI
- Brooks, 2003, PET studies on the function of dopamine in health and Parkinson's disease, Ann. N. Y. Acad. Sci, 991, 22, 10.1111/j.1749-6632.2003.tb07460.x · DOI
- Brooks, 2003, Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease, Exp. Neurol., 184, S68, 10.1016/j.expneurol.2003.08.008 · DOI · Paper page
- Brooks, 2006, Imaging in Parkinson's disease: the role of monoamines in behavior, Biol. Psychiatry, 59, 908, 10.1016/j.biopsych.2005.12.017 · DOI
- Bruck, 2001, Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus, Neurosci. Lett., 311, 81, 10.1016/S0304-3940(01)02124-3 · DOI · Paper page
- Cropley, 2008, Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA, Psychiatry Res., 163, 171, 10.1016/j.pscychresns.2007.11.003 · DOI
- Cumming, 1993, Pharmacokinetics of plasma 6-[18F]fluoro-l-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans, J. Cereb. Blood Flow Metab., 13, 668, 10.1038/jcbfm.1993.85 · DOI · Paper page
- Cumming, 1997, On the rate of decarboxylation of dopa to dopamine in the living mammillian brain, Ann. N. Y. Acad. Sci., 835, 274, 10.1111/j.1749-6632.1997.tb48637.x · DOI
- Danielsen, 2001, Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo, Synapse, 41, 172, 10.1002/syn.1071 · DOI · Paper page
- Dupont, 1990, Power and sample size calculations. A review and computer program, Control Clin. Trials, 11, 116, 10.1016/0197-2456(90)90005-M · DOI · Paper page
- Eshuis, 2009, Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls, Eur. J. Nucl. Med. Mol. Imaging, 36, 454, 10.1007/s00259-008-0989-5 · DOI · Paper page
- Grunder, 2003, Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo, Neuropsychopharmacology, 28, 787, 10.1038/sj.npp.1300103 · DOI
- Guttman, 1993, Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa, Mov. Disord., 8, 298, 10.1002/mds.870080308 · DOI
- Hammers, 2003, Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe, Hum. Brain Mapp., 19, 224, 10.1002/hbm.10123 · DOI · Paper page
- Hartvig, 1991, Brain kinetics of l-[beta-11C]dopa in humans studied by positron emission tomography, J. Neural. Transm. Gen. Sect., 86, 25, 10.1007/BF01250373 · DOI
- Heiss, 2004, The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease, Eur. J. Neurol., 11, 5, 10.1046/j.1351-5101.2003.00709.x · DOI
- Hirvonen, 2003, Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride, Nucl. Med. Commun., 24, 1207, 10.1097/00006231-200312000-00002 · DOI · Paper page
- Hoffman, 1992, The effects of carbidopa administration on 6-[18F]fluoro-l-dopa kinetics in positron emission tomography, J. Nucl. Med., 33, 1472
- Hoshi, 1993, 6-[18F]fluoro-l-dopa metabolism in living human brain: a comparison of six analytical methods, J. Cereb. Blood Flow Metab., 13, 57, 10.1038/jcbfm.1993.8 · DOI · Paper page
- Howes, 2007, Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis, Br. J. Psychiatry Suppl., 51, s13, 10.1192/bjp.191.51.s13 · DOI · Paper page
- Jokinen, 2009, Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls, J. Nucl. Med., 50, 893, 10.2967/jnumed.108.061572 · DOI · Paper page
- Kumakura, 2008, Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study, Neurobiol. Aging
- Lindemann, 2005, A renaissance in trace amines inspired by a novel GPCR family, Trends Pharmacol. Sci., 26, 274, 10.1016/j.tips.2005.03.007 · DOI · Paper page
- McGowan, 2004, Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study, Arch. Gen. Psychiatry, 61, 134, 10.1001/archpsyc.61.2.134 · DOI · Paper page
- Montgomery, 2006, Correction of head movement on PET studies: comparison of methods, J. Nucl. Med., 47, 1936
- Moore, 2003, Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study, Brain Res., 982, 137, 10.1016/S0006-8993(03)02721-5 · DOI
- Moore, 2008, Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study, Neurobiol. Dis., 29, 381, 10.1016/j.nbd.2007.09.004 · DOI · Paper page
- Nakamura, 2001, Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease, Ann. Neurol., 50, 181, 10.1002/ana.1075 · DOI · Paper page
- Nozaki, 2009, Regional dopamine synthesis in patients with schizophrenia using l-[beta-11C]DOPA PET, Schizophr. Res., 108, 78, 10.1016/j.schres.2008.11.006 · DOI · Paper page
- Ota, 2006, Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with l-[beta-11C]DOPA, Life Sci., 79, 730, 10.1016/j.lfs.2006.02.017 · DOI
- Patlak, 1985, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations, J. Cereb. Blood Flow Metab., 5, 584, 10.1038/jcbfm.1985.87 · DOI · Paper page
- Piccini, 2005, Factors affecting the clinical outcome after neural transplantation in Parkinson's disease, Brain, 128, 2977, 10.1093/brain/awh649 · DOI · Paper page
- Sawle, 1994, The effect of entacapone (OR-611) on brain [18F]-6-l-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease, Neurology, 44, 1292, 10.1212/WNL.44.7.1292 · DOI · Paper page
- Snow, 1993, Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels, Ann. Neurol., 34, 324, 10.1002/ana.410340304 · DOI · Paper page
- Studholme, 1996, Automated 3-D registration of MR and CT images of the head, Med. Image Anal., 1, 163, 10.1016/S1361-8415(96)80011-9 · DOI · Paper page
- Tedroff, 1998, Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity, Synapse, 28, 280, 10.1002/(SICI)1098-2396(199804)28:4<280::AID-SYN3>3.0.CO;2-5 · DOI
- Torstenson, 1998, Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone, Neuropharmacology, 37, 989, 10.1016/S0028-3908(98)00085-9 · DOI
- Turkheimer, 1999, Multiresolution analysis of emission tomography images in the wavelet domain, J. Cereb. Blood Flow Metab., 19, 1189, 10.1097/00004647-199911000-00003 · DOI · Paper page
- Vernaleken, 2007, 'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-l-DOPA-PET investigation, Hum. Brain Mapp., 28, 931, 10.1002/hbm.20325 · DOI · Paper page
- Vernaleken, 2006, Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge, Neuroimage, 30, 1332, 10.1016/j.neuroimage.2005.11.014 · DOI
- Vernaleken, 2008, Baseline [(18)F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects, Neuroimage, 40, 1222, 10.1016/j.neuroimage.2007.12.045 · DOI
- Vingerhoets, 1994, Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects, J. Nucl. Med., 35, 18
- Vingerhoets, 1996, Reproducibility and discriminating ability of fluorine-18-6-fluoro-l-DOPA PET in Parkinson's disease, J. Nucl. Med., 37, 421
- Whone, 2003, Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study, Ann. Neurol., 54, 93, 10.1002/ana.10609 · DOI · Paper page
Cited by
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Self-citationGlutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
“Decreased radiotracer binding following a pharmacological challenge that releases dopamine thus reflects increased extracellular dopamine (Egerton et al., 2010b).”
BackgroundMethodSelf-citationDopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Self-citationThe effects of Δ9-tetrahydrocannabinol on the dopamine system
Bloomfield, M. A. P., Ashok, A. H., Volkow, N. D., & Howes, O. D. (2016) · Nature · doi:10.1038/nature20153 · Cited by 373
Self-citationDopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010160 · Cited by 343
Self-citation
Metadata
- Authors
- Egerton, A., Demjaha, A., McGuire, P., Mehta, M. A., & Howes, O. D.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 50
- Issue
- 2
- Pages
- 524-531
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2085960980
- Cited by
- 134
- References
- 7
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Medical Research Council, UK
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The test–retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. https://app.cochat.ai/papers/10.1016/j.neuroimage.2009.12.058
- The paper
- Egerton, A., Demjaha, A., McGuire, P., Mehta, M. A., & Howes, O. D. (2010). The test–retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. NeuroImage. https://doi.org/10.1016/j.neuroimage.2009.12.058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.